WuXi Biologics (Cayman) Inc. (HKG:2269)

Hong Kong · Delayed Price · Currency is HKD

31.36

-1.00 (-3.09%)

Mar 30, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Adjustments and Eliminations	-2.29B	-1.89B	-1.12B	-726.52M	-
Biologics	18.14B	16.51B	16.03B	15.00B	-
Biologics Growth	9.88%	2.97%	6.85%	-	-
Xdc	5.94B	4.05B	2.12B	990.42M	-
Xdc Growth	46.69%	90.80%	114.44%	-	-
Biotechnology	-	-	-	-	10.29B
Biotechnology Growth	-	-	-	-	83.35%
Total	21.79B	18.68B	17.03B	15.27B	10.29B
Total Growth	16.68%	9.63%	11.56%	48.38%	83.35%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
North America	12.65B	10.70B	8.07B	8.50B	5.23B
North America Growth	18.30%	32.48%	-4.98%	62.49%	110.91%
Europe	5.04B	4.32B	5.14B	2.55B	2.28B
Europe Growth	16.64%	-15.91%	101.90%	11.86%	409.68%
People's Republic of China (PRC)	2.68B	2.82B	3.12B	3.72B	2.51B
People's Republic of China (PRC) Growth	-4.99%	-9.65%	-16.07%	48.13%	1.89%
Rest of The World	1.41B	836.35M	698.48M	507.08M	274.18M
Rest of The World Growth	69.13%	19.74%	37.75%	84.94%	23.22%
Total	21.79B	18.68B	17.03B	15.27B	10.29B
Total Growth	16.68%	9.63%	11.56%	48.38%	83.35%

Source: S&P Global Market Intelligence.